FindTrial
Sign In

Methylphenidate Transdermal System

DRUG11 trials

Sponsors

Noven Therapeutics, University of Oklahoma, University of Virginia, Massachusetts General Hospital, Duke University

Conditions

ADHDAttention Deficit Disorder With HyperactivityAttention Deficit Hyperactivity DisorderAutism

Phase 2

Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD
CompletedNCT00151970
Noven TherapeuticsAttention Deficit Disorder With Hyperactivity
Start: 2005-06-30End: 2006-10-31Updated: 2015-07-09
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
CompletedNCT00466791
Noven TherapeuticsAttention Deficit Disorder With Hyperactivity
Start: 2004-08-31End: 2005-05-31Updated: 2015-06-25

Phase 3

Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
CompletedNCT00151983
Noven TherapeuticsAttention Deficit Disorder With Hyperactivity
Start: 2005-06-30End: 2006-07-31Updated: 2015-07-09
Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials
CompletedNCT00151957
Noven TherapeuticsAttention Deficit Disorder With Hyperactivity
Start: 2004-10-31End: 2007-06-30Updated: 2017-03-28
Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD
CompletedNCT00444574
Noven TherapeuticsAttention Deficit Hyperactivity Disorder
Start: 2004-09-30End: 2005-06-30Updated: 2015-06-25
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
CompletedNCT00499863
Noven TherapeuticsADHD
Start: 2007-07-31End: 2008-05-31Updated: 2017-04-26
Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
CompletedNCT00501293
Noven TherapeuticsADHD
Start: 2007-08-31End: 2009-02-28Updated: 2017-04-26
A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms
CompletedNCT00541346
University of OklahomaAttention Deficit Hyperactivity Disorder, Autism
Start: 2007-09-30End: 2010-02-28Updated: 2014-02-06

Phase 4

Study of Medication Patch to Treat Children Ages 6-12 With ADHD
CompletedNCT00586157
Massachusetts General HospitalADHD, Attention Deficit Hyperactivity Disorder
Start: 2006-09-30End: 2008-12-31Updated: 2012-11-16
Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)
CompletedNCT00889915
Duke UniversityAttention Deficit Disorder With Hyperactivity
Start: 2009-04-30End: 2009-12-31Updated: 2013-09-30

Unknown Phase

Enhancing ADHD Driving Performance With Stimulant Medication
NCT00572026
University of VirginiaAttention Deficit Hyperactivity Disorder
Start: 2007-07-31End: 2009-07-31Target: 14Updated: 2009-09-03

Related Papers

A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.
2010-05-0120 citations
Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion.
2010-01-0110 citations
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
2009-12-1013 citations
HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.
2009-12-0119 citations
Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
2009-08-0132 citations
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.
2008-01-0171 citations